Results 31 to 40 of about 77 (65)

Trends in Graves' orbitopathy research in the past two decades: a bibliometric analysis. [PDF]

open access: yesArq Bras Oftalmol, 2022
Elubous KA   +5 more
europepmc   +1 more source

Oftalmopatia de Graves e qualidade de vida após o tratamento

open access: yes, 2014
Introduction: Graves 'ophthalmopathy is an autoimmune manifestation that occurs in 90% of patients with Graves' disease, more common in females. It is characterized by the presence of eyelid edema, conjunctival hyperemia, itching, excessive tearing, proptosis, photophobia, diplopia and difficulty in ocular motility.
openaire   +1 more source

[Pretibial myxoedema in Graves' disease]. [PDF]

open access: yesAten Primaria, 2019
Tomás-Velázquez A   +2 more
europepmc   +1 more source

Botulinum toxin for treatment of restrictive strabismus. [PDF]

open access: yesJ Optom, 2017
Merino PS   +4 more
europepmc   +1 more source

Surgical complications in orbital decompression for Graves' orbitopathy. [PDF]

open access: yesActa Otorhinolaryngol Ital, 2016
Sellari-Franceschini S   +8 more
europepmc   +1 more source

[Thyroid disease in pregnancy]. [PDF]

open access: yesAten Primaria, 2001
Puigdevall V   +5 more
europepmc   +1 more source

Eficácia das terapias convencionais (Pentoxifilina e Nicotinamida/Alopurinol) comparadas a metilprednisolona intravenosa no tratamento da oftalmopatia de Graves

open access: yes, 2014
A oftalmopatia de Graves (OG) se constitui em uma das manifestações clínicas mais marcantes da Doença de Graves. Mais freqüente em mulheres, pode atingir qualquer faixa etária e produzir alterações negativas na qualidade de vida dos pacientes acometidos.
openaire   +1 more source

[Female with peau d́orange legs and hyperthyroidism]. [PDF]

open access: yesAten Primaria
Labrador-Descalzo S   +2 more
europepmc   +1 more source

Morphometric analysis of extraocular muscles and proptosis by computed tomography in Graves' orbitopathy. [PDF]

open access: yesRadiol Bras
Watanabe EM   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy